HEALTHSTAT NEWS
STAT+: Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?
Eli Lilly provided access to its experimental obesity drug retatrutide to a 79-year-old man through the FDA’s compassionate use program. The case drew interest from top health officials, suggesting the recipient was well connected.
Mentioned
Related Signal
Adjacent reporting
- Healthy Returns: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight
- Woman, 77, shares her experience of taking new 'Mounjaro pill' as medication gets green light in the US
- STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end
- Eli Lilly says its next gen obesity drug is more powerful than Zepbound and Wegovy
- Bowls-loving 'drug mule', 80, is freed from Chile jail over 'health concerns'